Randomized clinical trial of the efficacy of the EmoLED medical device in the treatment of stage 2 and stage 3 pressure ulcers: The RISE_UP study
The result shows that blue light photobiomodulation promotes recovery of tissue repair in pressure ulcers, and in stabilizing wounds that would otherwise worsen despite standard of care treatment. This therapy may be a valuable contribution to the daily management of pressure lesions since it has an excellent safety profile and the addition of this therapy to a treatment program may speed healing, improving the quality of life. (Clinicaltrials.gov Ref. numb.: NCT05130814).
Authors
- Marina Giuliano (ORCID: https://orcid.org/0000-0003-2789-7797)
- Mara Dalladonna
- Michele Rossi (ORCID: https://orcid.org/0000-0002-1532-0002)
- Claudio Macchi (ORCID: https://orcid.org/0000-0003-2265-3216)
- Paolo Iovino (ORCID: https://orcid.org/0000-0001-5952-881X)
- Emanuele Buccione (ORCID: https://orcid.org/0000-0003-4146-8948)
- Hamilton Dollaku (ORCID: https://orcid.org/0000-0002-0559-5264)
- Paola Barbetti
- Maria Sipontina Marcolongo
Institutions
- Fondazione Golgi Cenci (IT)
- Don Carlo Gnocchi Foundation (IT)
- Azienda USL di Pescara (IT)
- University of Florence (IT)
Publication Details
- Journal
- Journal of Tissue Viability
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1016/j.jtv.2025.100895
- Citations
- 2
- Primary Topic
- Pressure Ulcer Prevention and Management
- Type
- article
- Field-Weighted Citation Impact
- 11.55